Rugo HS, Im SA, Cardoso F, Cortes J, et al. Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial. J Clin Oncol 2022 Nov 4:JCO2102937. doi: 10.1200/JCO.21.02937.
PMID: 36332179